Embracing the Insulin Revolution in the Ambulatory Care Setting.
Diabetes Spectr
; 29(3): 140-5, 2016 Aug.
Article
in En
| MEDLINE
| ID: mdl-27574367
ABSTRACT
IN BRIEF Recent additions of various new formulations of insulin to the U.S. marketplace have increased the number of treatment options available to people living with diabetes. However, it is important to take into consideration the implications of these new insulins in terms of patient safety and medication errors, integration with electronic medical records, and financial considerations. This review outlines several considerations for practitioners regarding the implications of these new insulin products for ambulatory care practice.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Diabetes Spectr
Year:
2016
Type:
Article
Affiliation country:
Macao